AbCellera Biologics Inc vs GameStop Corp. — how do they compare? AbCellera Biologics Inc trades at $10.98 (market cap $3.17B), while GameStop Corp. trades at $18.6 (market cap $8.32B). The key difference: GameStop Corp. is far larger — about 2.6× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, GameStop Corp. nearer its low. Which is the better fit depends on your goals.
| ABCL | GME | |
|---|---|---|
Market Cap | $3.17B | $8.32B |
Sector | Health | Consumer Cyclical |
52-Week High | $10.36 | $27.69 |
52-Week Low | $2.78 | $18.54 |
Enterprise Value | $2.77B | $4.29B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →